AI Ethics & Responsible Technology
Speakers who interrogate the human consequences of algorithmic decision-making, data ethics and emerging technology
Boards have approved AI pilots, signed responsible-AI principles, and named ethics committees, and still cannot answer whether their deployed systems would survive a regulator’s audit or a serious public failure. The gap is not awareness. It is the operating distance between governance language and the decisions engineers, product leads and procurement teams actually make every week.
Most boards still treat AI as a software question their CIO will solve. The story is bigger than that. The contest is over compute, fabs, energy supply, and the sovereign infrastructure that will decide which companies and which countries hold the next decade of pricing power. Leaders who frame AI as a productivity tool are already a strategy cycle behind.
Most enterprise AI programmes stall between pilot and operating advantage. Boards have approved the spend, vendors have shipped the tools, and the value is still trapped in slideware. The tension now is governance, accountability and workforce redesign at the speed agentic AI is moving, not whether to invest.
Boards now operate inside a thicker regulatory perimeter than at any point in the post-2008 cycle, with competition, digital and capital markets rules tightening at EU and national level at once. Most leadership teams read these moves as compliance cost, not as a market signal. The blind spot is structural. Pricing, M&A, data strategy and capital allocation are all being repriced by regulators while executives still treat regulation as a downstream constraint.
Most organisations have committed to an AI strategy. Very few have built the governance architecture to make that strategy accountable at scale. The gap between an approved AI roadmap and actual enterprise-wide adoption is where initiatives stall, risk accumulates, and boards are left approving decisions they cannot yet evaluate. Closing that gap requires a different kind of expertise – one built inside organisations, not just around them.
Boards are being asked to make calls on artificial intelligence and health technology before the evidence base has settled. Most senior teams have a strong grasp of the hype cycle and a weak grasp of what the science actually supports, where the ethical exposure sits, and which innovations will reach customers and workforces inside the planning horizon. The gap between confident vendor pitches and defensible internal judgement is widening.
Most enterprise AI programmes are stuck between an executive mandate to deploy and an operating reality that cannot absorb the change. Boards want commercial returns. Workforces want to know what happens to them. Risk and compliance want to know how the model decides. The leaders running these programmes need someone who has actually shipped AI inside large companies, not someone describing the journey from outside.
Most boards now treat AI as a strategic priority without a grounded view of how the systems setting that pace are actually built. Executive advice tends to swing between technical detail no operator needs and speculation no fiduciary can act on. The view from inside a frontier lab is rarely in the room with the people who most need it.
Sustainable advantage has collapsed for most early-stage businesses. Distribution is cheap, features are copied within weeks, and capital alone no longer protects a category position. The companies that hold ground are the ones whose customers, contributors and earliest believers are bound to the product by something the balance sheet cannot buy.
Most enterprises now have an AI strategy on paper and very little operating advantage to show for it. Pilots stall, governance is improvised, and the gap between board ambition and frontline deployment keeps widening. Leaders need a credible operator who has built AI inside a Fortune 500 and shaped it inside the United Nations, not another commentator describing the trend.
Most enterprises have bought into generative AI in principle and stalled in practice. Pilots multiply, demos impress, but very few make the jump to operating on proprietary data inside real workflows. The hard question for boards is no longer whether to adopt AI, but how to make it useful at scale without losing control of accessibility, governance and the workforce alongside it.
Most diversity programmes have stopped producing measurable change. Budgets stay flat or fall, while the political cost of running them rises. Leaders need someone who can rebuild equity as an operating practice inside talent processes, products, and AI tooling, not as a campaign that lives on the side.